Regeneron to Seek FDA Approval for Its COVID-19 Antibody Cocktail to Be Used for Prevention
Regeneron Pharmaceuticals is pursuing FDA approval for its antibody cocktail to be used as a preventative treatment for COVID-19.
Stay updated with breaking news from Prevention Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regeneron Pharmaceuticals is pursuing FDA approval for its antibody cocktail to be used as a preventative treatment for COVID-19.
HEALTH-CORONAVIRUS/ROCHE-REGENERON PHARMS (UPDATE 2):UPDATE 2-Regeneron to seek U.S. OK for COVID-19 cocktail to be used for prevention
The drug, if authorized, could offer another line of defense against the disease.
Regeneron says its cocktail can help prevent infection; Britain starts opening up: Live COVID-19 updates John Bacon and Elinor Aspegren, USA TODAY These 'vaccine fairies' are helping people in need get their COVID-19 shots Replay Video UP NEXT Regeneron Pharmaceuticals announced Monday that a Phase 3 trial of its antibody cocktail offered strong protection against COVID-19 for people living with someone infected with the coronavirus. The treatment lessens the likelihood of infection and improves outcomes for those who do become infected, Regeneron said in a statement. The ...
Regeneron, Roche injectable antibody drug shows efficacy in preventing Covid-19 A Regeneron Pharmaceuticals antibody cocktail currently authorized for treating Covid-19 now has additional clinical data showing it reduces the risk of infection spread. The drug developer, along with partner Roche, plan to ask regulators to expand the drug’s authorization to include disease prevention. Shares0 A Covid-19 antibody cocktail developed by Regeneron Pharmaceuticals and Roche has pivotal clinical trial data showing it protected against the spread of infection among people in the same household. The...